Top Markets
#1 Akedo Akedo +60.74%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.99%
#4 Velvet Velvet +41.65%
#5 Black Phoenix Black Phoenix +34.54%
#6 τemplar τemplar +26.67%
#7 Ribbita by Virtuals Ribbita by Virtuals +18.82%
#8 Bitway Bitway +17.84%
#9 Cap Cap +17.11%
#10 Perle Perle +15.44%
Coin of the day
Akedo Akedo
設定
言語
日本
通貨
USD
テーマ
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
株式のランク #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
株価
$1.51
最終同期: 2024-08-26
時価総額
$1.12M
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Agile Therapeutics, Inc. (AGRX)

カテゴリー

Healthcare
Agile Therapeutics, Inc.（AGRX）の収益
Jun 2024 時点の収益 TTM: $21.57M
Agile Therapeutics, Inc. の最新の財務報告によると、現在の収益 (TTM) は $21.57M です。2022 年には $10.88M の収益があり、これは 2021 年の $4.10M と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Agile Therapeutics, Inc. の収益履歴（2012 ～ 2026）
各年末の収益
年 収益 変化
2026 (TTM) $21.57M 10.08%
2023 $19.59M 80.02%
2022 $10.88M 165.40%
2021 $4.10M 447.53%
2020 $749.00K 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
2013 0.00 0.00%
2012 0.00 0.00%
同業他社の収益
企業 収益 収益の差 国
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B 30,554.91%
IN